TY - JOUR
T1 - Endemic polycythemia in Russia
T2 - Mutation in the VHL gene
AU - Ang, Sonny O.
AU - Chen, Hua
AU - Gordeuk, Victor R.
AU - Sergueeva, Adelina I.
AU - Polyakova, Lydia A.
AU - Miasnikova, Galina Y.
AU - Kralovics, Robert
AU - Stockton, David W.
AU - Prchal, Josef T.
N1 - Funding Information:
This work was supported by Grants R01HL66333-01, R01HL5007-08 NHLBI, and UH1 HL03679-03 from the National Heart, Lung, and Blood Institute, National Institutes of Health (Bethesda, MD).
PY - 2002
Y1 - 2002
N2 - Chuvash polycythemia (CP) is an autosomal recessive condition that is endemic in the Russian mid-Volga River region of Chuvashia. We previously found that CP patients may have increased serum erythropoietin (EPO) levels, ruled out linkage to both the EPO and EPO receptor (EPOR) gene loci, and hypothesized that the defect may lie in the oxygen homeostasis pathway. We now report a study of five multiplex Chuvash families which confirms that CP is associated with significant elevations of serum EPO levels and rules out a location for the CP gene on chromosome 11 as had been reported by other investigators or a mutation of the HIF-1α gene. Using a genome-wide screen, we localized a region on chromosome 3 with a LOD score >2. After sequencing three candidate genes, we identified a C to T transition at nucleotide 598 (an R200W mutation) in the von Hippel-Lindau (VHL) gene. The VHL protein (pVHL) downregulates the alpha subunit of hypoxia-inducible factor 1 (HIF-1α), the main regulator of hypoxia adaptation, by targeting the protein for degradation. In the simplest scenario, disruption of pVHL function causes a failure to degrade HIF-1α resulting in accumulation of HIF-1α, upregulation of downstream target genes such as EPO, and the clinical manifestation of polycythemia. These findings strongly suggest that CP is a congenital disorder of oxygen homeostasis.
AB - Chuvash polycythemia (CP) is an autosomal recessive condition that is endemic in the Russian mid-Volga River region of Chuvashia. We previously found that CP patients may have increased serum erythropoietin (EPO) levels, ruled out linkage to both the EPO and EPO receptor (EPOR) gene loci, and hypothesized that the defect may lie in the oxygen homeostasis pathway. We now report a study of five multiplex Chuvash families which confirms that CP is associated with significant elevations of serum EPO levels and rules out a location for the CP gene on chromosome 11 as had been reported by other investigators or a mutation of the HIF-1α gene. Using a genome-wide screen, we localized a region on chromosome 3 with a LOD score >2. After sequencing three candidate genes, we identified a C to T transition at nucleotide 598 (an R200W mutation) in the von Hippel-Lindau (VHL) gene. The VHL protein (pVHL) downregulates the alpha subunit of hypoxia-inducible factor 1 (HIF-1α), the main regulator of hypoxia adaptation, by targeting the protein for degradation. In the simplest scenario, disruption of pVHL function causes a failure to degrade HIF-1α resulting in accumulation of HIF-1α, upregulation of downstream target genes such as EPO, and the clinical manifestation of polycythemia. These findings strongly suggest that CP is a congenital disorder of oxygen homeostasis.
UR - http://www.scopus.com/inward/record.url?scp=0036111623&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036111623&partnerID=8YFLogxK
U2 - 10.1006/bcmd.2002.0488
DO - 10.1006/bcmd.2002.0488
M3 - Article
C2 - 11987242
AN - SCOPUS:0036111623
SN - 1079-9796
VL - 28
SP - 57
EP - 62
JO - Blood Cells, Molecules, and Diseases
JF - Blood Cells, Molecules, and Diseases
IS - 1
ER -